Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
Theracor is derived from human umbilical cord extracellular matrix (ECM) and is designed to cover, protect, and maintain a moist wound environment
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The new site marks the company’s first operation in the region
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Subscribe To Our Newsletter & Stay Updated